Koers BioLight Life Sciences Ltd TEL AVIV STOCK EXCHANGE
Aandelen
IL0010952237
Geavanceerde medische apparatuur & technologie
Omzet 2022 | 63K 16,78K 6,3 mln. 15,7K | Omzet 2023 | 118K 31,43K 11,8 mln. 29,41K | Marktkapitalisatie | 24,12 mln. 6,42 mln. 2,41 mld. 6,01 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | -7 mln. -1,86 mln. -700 mln. -1,74 mln. | Nettowinst (verlies) 2023 | -26 mln. -6,92 mln. -2,6 mld. -6,48 mln. | EV/omzet 2022 | 207 x |
Nettoliquiditeiten 2022 | 17,1 mln. 4,55 mln. 1,71 mld. 4,26 mln. | Nettoliquiditeiten 2023 | 8,55 mln. 2,28 mln. 855 mln. 2,13 mln. | EV/omzet 2023 | 132 x |
K/w-verhouding 2022 |
-3,85
x | K/w-verhouding 2023 |
-0,93
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 43,16% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 54 | 01-05-20 | |
Yifftach Biel
DFI | Director of Finance/CFO | 48 | 01-05-15 |
Ron Neumann
CTO | Chief Tech/Sci/R&D Officer | 69 | 01-12-19 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Israel Makov
CHM | Chairman | 85 | 21-04-11 |
Kobi Faigenbaum
BRD | Director/Board Member | 71 | 11-05-17 |
Alla Felder
BRD | Director/Board Member | 50 | 25-03-20 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+7,83% | 217 mld. | |
+6,03% | 183 mld. | |
+10,35% | 131 mld. | |
+24,64% | 106 mld. | |
-0,95% | 62,16 mld. | |
+10,31% | 51,02 mld. | |
+4,81% | 50,89 mld. | |
-0,97% | 40,16 mld. | |
+0,48% | 34,79 mld. |